Billie Kenneth Koe

Billie Kenneth Koe's AcademicInfluence.com Rankings

Billie Kenneth Koe

Medical

#3239

World Rank

#3697

Historical Rank

Pharmacology

#393

World Rank

#445

Historical Rank

medical Degrees

Download Badge

Medical

Billie Kenneth Koe's Degrees

Bachelors Pharmacy University of California, San Francisco

Why Is Billie Kenneth Koe Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Billie Kenneth Koe's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

p-Chlorophenylalanine: a specific depletor of brain serotonin. (1966) (1767)
Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. (1976) (505)
Antiamphetamine effects following inhibition of tyrosine hydroxylase. (1966) (455)
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. (1990) (335)
Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. (1983) (229)
Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins. (1984) (159)
Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. (1991) (135)
Behavioral effects of L-α-methyltyrosine, an inhibitor of tyrosine hydroxylase (1965) (134)
The pharmacology of para-chlorophenylalanine, a selective depletor of serotonin stores. (1968) (106)
Clinical‐pharmacological evaluation of p‐chlorophenylalanine: A new serotonin‐depleting agent (1966) (72)
Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. (1990) (65)
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase. (1991) (63)
Pharmacology of sertraline: a review. (1988) (62)
Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats. (1988) (58)
A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindoles. (1989) (56)
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one: A Potent and Selective Serotonin (5-HT1B) Agonist and Rotationally Restricted Phenolic Analogue of 5-Methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. (1991) (56)
Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines. (1980) (45)
Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics. (1985) (42)
Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones. (1991) (41)
Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain. (1987) (36)
m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism. (1967) (34)
An instance of the occurrence of carcinogenic substances in certain barnacles. (1951) (27)
5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity. (1994) (27)
Stepwise Dehydrogenation of the Colorless Polyenes Phytoene and Phytofluene with N-Bromosuccinimide to Carotenoid Pigments (1954) (26)
Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites. (1983) (26)
Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain. (1989) (25)
1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors. (1992) (24)
The isolation of carcinogenic and other polycyclic aromatic hydrocarbons from barnacles. (1952) (24)
4‐Amino(1,2,4)triazolo(4,3‐a)quinoxalines. A Novel Class of Potent Adenosine Receptor Antagonists and Potential Rapid‐Onset Antidepressants. (1991) (24)
[3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs. (1987) (23)
Stereospecific and potent analgetic activity for nantradol--a structurally novel, cannabinoid-related analgetic. (1979) (23)
Inhibiting action of n-butyraldoxime on ethanol metabolism and on natural ethanol preference of C57BL mice. (1970) (21)
Preparation and spectral characteristics of all trans- and a cis-phytofluene. (1953) (21)
Blockade of heart 3H-norepinephrine up-take by 4-phenyl-1-aminotetralines: implications for the active conformation of imipramine-like drugs. (1974) (20)
(+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine binding to σ receptors in mouse brain in vivo (1989) (20)
Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin. (1992) (19)
GABA‐like Actions of Levonantradol (1981) (18)
In vitro conversion of phytofluene and phytoene into carotenoid pigments. (1952) (18)
Neuroleptic activity of the 5-aryltetrahydro-gamma-carboline series. Conformational requirements for interaction with central dopamine receptors. (1980) (17)
Contrasting effects of ethyl beta-carboline-3-carboxylate (beta CCE) and diazepam on cerebellar cyclic GMP content and antagonism of both effects by Ro 15-1788, a specific benzodiazepine receptor blocker. (1983) (17)
PA 132, a new antibiotic. I. Isolation and chemical properties. (1956) (16)
Dependence of m-fluorophenylalanine toxicity on phenylalanine hydroxylase activity. (1967) (14)
Facilitation of Benzodiazepine Binding by Levonantradol (1981) (13)
Calcium-Independent Phosphodiesterase Inhibitors as Putative Antidepressants: (3-(Bicycloalkoxy)-4-methoxyphenyl)-2- imidazolidinones. (1991) (13)
Neuroleptics from the 4a,9b-cis- and 4a,9b-trans-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole series. 2. (1986) (13)
The isolation of carcinogenic and other polycyclic aromatic hydrocarbons from barnacles. II. The goose barnacle (Mitella polymerus). (1952) (13)
ONE WAY CROSS TOLERANCE FROM MORPHINE TO NANTRADOL - A POTENT, NON-OPIOID ANALGETIC (1980) (13)
Enhancement of benzodiazepine binding by methaqualone and related quinazolinones (1986) (13)
Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines. (1986) (12)
Convulsions and elevation of tissue citric acid levels induced by 5-fluorotryptophan. (1966) (12)
Chapter 5. Adaptive Changes in Central Nervous System Receptor Systems (1984) (11)
Blockade of hepatic aldehyde dehydrogenase in mice on chronic ingestion of 4-bromopyrazole and 4-iodopyrazole. (1975) (11)
Enhancement of benzodiazepine binding by progabide (SL 76002) and SL 75102 (1983) (10)
Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding. (1991) (10)
Stereoisomerization of the polycis compounds, pro-γ-carotene and prolycopene in chickens and hens. (1951) (9)
[3H] sertraline binding to rat brain membranes (2005) (8)
Synthesis and dopamine autoreceptor activity of a 5-(methylmercapto)methyl-substituted derivative of (+/-)-3-PPP (3-(3-hydroxyphenyl)-1-n-propylpiperidine). (1985) (8)
Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase. (1965) (8)
ISOLATION AND CHARACTERIZATION OF URINARY METABOLITES OF BENZQUINAMIDE AND BENZQUINAMIDE ALCOHOL. (1964) (8)
CP-93,129: A Potent and Selective Agonist for the Serotonin (5-HT1B) Receptor and Rotationally Restricted Analog of RU-24,969 (1991) (7)
A common mechanism of action for antidepressant drugs (1983) (7)
BIOCHEMICAL ASSESSMENT OF THE NEUROLEPTIC ACTIVITY OF MOLINDONE (1979) (7)
Chapter 22. Drugs and Deterrence of Alcohol Consumption (1969) (6)
Inhibition of rat brain tryptophan hydroxylation with p-chloroamphetamine. (1976) (6)
Structure‐Activity Relationship of Quinazolinedione Inhibitors of Calcium‐Independent Phosphodiesterase. (1991) (6)
Inhibiting Action of p-Chlorophenylalanine and α-Methyl-p-chlorophenylalanine on Liver Phenylalanine and Tryptophan Hydroxylase (1967) (6)
Levonantradol, a potent cannabinoid-related analgesic, antagonizes haloperidol-induced activation of striatal dopamine synthesis. (1981) (6)
4a,9b-trans-8-Fluoro-5-(4-fluorophenyl)-2-[4-(4-fluorophenyl)-4-hydroxybutyl]-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole hydrochloride, a new potent neuroleptic. (1980) (6)
Synthesis of 5‐(2,3‐ditritiopropoxy)‐3‐(1,2,5,6‐tetrahydropyrid‐4‐yl)indole ([3H]CP‐96,501): A selective ligand for the serotonin (5‐HT1B) receptor (1991) (5)
PREPARATION AND ANTIBIOTIC PROPERTIES OF SOME PHOSPHINYLAMINOPENICILLANIC ACIDS AND PHOSPHINOTHIOYLAMINOPENICILLANIC ACIDS. (1963) (5)
Pa 150, PA 153, and PA 166: new polyene antifungal antibiotics. (1957) (5)
Tryptophan hydroxylase inhibitors. (1971) (5)
LOWER 2'-ALKYLTHIO ANALOGS AND DERIVATIVES OF GRISEOFULVIN VIA A MERCAPTANOLYSIS REACTION. (1964) (4)
5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl] benzimidazole (CP-161,242): A potent, centrally active 5-HT1D receptor agonist and benzodiazepine partial agonist (1995) (4)
NONTRICYCLIC ANTIDEPRESSANT AGENTS DERIVED FROM CIS- AND TRANS-1-AMINO-4-ARYLTETRALINS (1985) (3)
Some fluorescent substances contained in the marine "blood worm" (Thoracophelia mucronata). (1952) (3)
NEUROLEPTIC ACTIVITY IN 5-ARYLTETRAHYDRO-Γ-CARBOLINES (1980) (3)
Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: Implications for the treatment of tardive dyskinesia (1975) (3)
Blockade of ethanol metabolism and reduced alcohol selection in c57bl mice by butyraldoxime. Abstr. (1969) (2)
Oxindole N-Methyl-D-Aspartate (NMDA) antagonists (1993) (2)
The nature of some fluorescing substances contained in a deep-sea mud. (1950) (2)
Effects of serotoninergic agents on downregulation of beta-adrenoceptors by the selective serotonin reuptake inhibitor sertraline. (1995) (2)
Blocking H 3 -Norepinephrine uptake and some guanethidine-induced effects with tricyclic psychotherapeutic drugs. (1972) (2)
Dopamine receptor blockade by imidoline and its proposed active conformation. (1980) (1)
D 1 and d 2 dopamine receptor antagonist character of selected neuroleptics (1985) (1)
Clinical and biochemical effects of fenclonine: a serotonin depletor. (1968) (1)
Contrasting locomotor effects of catecholamine releasers and tyrosine hydroxylase inhibitors in MAO-inhibited mice (1967) (1)
Neuroleptics from the 4a,9b-trans-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole series. 3. Carboxamidoalkyl derivatives. (1986) (1)
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives as therapeutic agent of psychosis (1994) (0)
5‐Cyano‐1‐(3‐(N‐methylpyrrolidin‐2R‐ylmethyl)indol‐5‐yl)benzimidazole ( CP‐161,242): A Potent, Centrally Active 5‐HT1D Receptor Agonist and Benzodiazepine Partial Agonist. (1996) (0)
The Isolation and Study of Some Naturally Occurring Fluorescent Organic Compounds and Stereoisomerization of Prolycopene, Pro-γ-Carotene, and Lycopene in Chickens and Hens (1952) (0)
Stereoisomerization of the polycis compounds, pro-gamma-carotene and prolycopene in chickens and hens. (1951) (0)
Analogifremgangsmaade for the preparation of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalene-amine derivatives in racemic form or as optically active (1S) -enantiomers or pharmaceutically acceptable acid addition salts thereof (1980) (0)
Neuroleptics from the 4a,9b-cis- and 4a,9b-trans-2,3,4,4a,5,9b-Hexahydro-1H-pyrido(4,3-b)indole Series. Part 2. (1987) (0)
(+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine binding to sigma receptors in mouse brain in vivo. (1989) (0)
Nicotinamide Ethers: Novel Inhibitors of Calcium-Independent Phosphodiesterase and (3H)Rolipram Binding. (1991) (0)
Analogifremgangsmaate for preparing therapeutically active 4-phenyl-1,2,3,4-tetrahydro-1-naftalenaminderivater (1980) (0)
Neuroleptic Activity of Chiral trans‐Hexahydro‐γ‐carbolines. (2002) (0)
Process for the preparation of trans-4-phenyl-1,2,-3,4-tetrahydro-1-naphthalen amine derivatives (1980) (0)
Saccharin preference of butyraldoxime-treated C57BL mice (1972) (0)
A process for preparing trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives or pharmaceutically acceptable acid addition salts thereof (1980) (0)
Antagonism of 5-hydroxytryptamine by benzquinamide (1966) (0)
SYNTHESIS AND DOPAMINE AUTORECEPTOR ACTIVITY OF A 5-(METHYLMERCAPTO)METHYL-SUBSTITUTED DERIVATIVE OF(.+-.)-3-PPP (3-(3-HYDROXYPHENYL)-1-PROPYLPIPERIDINE) (1985) (0)
A process for preparing cis-4-phenyl1,2,3,4-tetrahydro-1-naphthalenamine derivatives or acid addition salts thereof (1980) (0)
4A,9B-TRANS-8-FLUORO-5-(4-FLUOROPHENYL)-2-(4-(4-FLUOROPHENYL)-4-HYDROXYBUTYL)-2,3,4,4A,5,9B-HEXAHYDRO-1H-PYRIDO(4,3-B)INDOLE HYDROCHLORIDE, A NEW POTENT NEUROLEPTIC (1981) (0)
Antidepressiva of the derivative of trans-4-phenyl-1,2,3,4-tetrahydro-1-Naphthalenamine (1980) (0)
BIOCHEMICAL AND BEHAVIORAL EFFECTS OF DESMETHYLSERTRALINE (1992) (0)
6-Aminopenicillanamide and Methyl 6-Aminopenicillanate (1962) (0)
The progress analogy for the preparation of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives thereof or pharmaceutically acceptablesyreadditionssalte (1980) (0)
Additions and Corrections - Neuroleptic Activity of Chiral trans-Hexahrdro-γ-carbolines. (1986) (0)
A Novel Class of “GABAergic” Agents: 1-Aryl-3-(aminoalkylidene)oxindoles. (1989) (0)
Neuroleptics from the 4a,9b-trans-2,3,4,4a,5,9b-Hexahydro-1H-pyrido-(4,3-b)indole Series. Part 3. Carboxamidoalkyl Derivatives. (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Billie Kenneth Koe?

Billie Kenneth Koe is affiliated with the following schools:

California Institute of Technology